How we treat brain metastases in metastatic renal cell carcinoma.
Publication
, Journal Article
Ramalingam, S; George, DJ; Harrison, MR
Published in: Clin Adv Hematol Oncol
February 2018
Duke Scholars
Published In
Clin Adv Hematol Oncol
ISSN
1543-0790
Publication Date
February 2018
Volume
16
Issue
2
Start / End Page
110 / 114
Location
United States
Related Subject Headings
- Treatment Outcome
- Oncology & Carcinogenesis
- Kidney Neoplasms
- Humans
- Disease Management
- Combined Modality Therapy
- Carcinoma, Renal Cell
- Brain Neoplasms
Citation
APA
Chicago
ICMJE
MLA
NLM
Ramalingam, S., George, D. J., & Harrison, M. R. (2018). How we treat brain metastases in metastatic renal cell carcinoma. Clin Adv Hematol Oncol, 16(2), 110–114.
Ramalingam, Sundhar, Daniel J. George, and Michael R. Harrison. “How we treat brain metastases in metastatic renal cell carcinoma.” Clin Adv Hematol Oncol 16, no. 2 (February 2018): 110–14.
Ramalingam S, George DJ, Harrison MR. How we treat brain metastases in metastatic renal cell carcinoma. Clin Adv Hematol Oncol. 2018 Feb;16(2):110–4.
Ramalingam, Sundhar, et al. “How we treat brain metastases in metastatic renal cell carcinoma.” Clin Adv Hematol Oncol, vol. 16, no. 2, Feb. 2018, pp. 110–14.
Ramalingam S, George DJ, Harrison MR. How we treat brain metastases in metastatic renal cell carcinoma. Clin Adv Hematol Oncol. 2018 Feb;16(2):110–114.
Published In
Clin Adv Hematol Oncol
ISSN
1543-0790
Publication Date
February 2018
Volume
16
Issue
2
Start / End Page
110 / 114
Location
United States
Related Subject Headings
- Treatment Outcome
- Oncology & Carcinogenesis
- Kidney Neoplasms
- Humans
- Disease Management
- Combined Modality Therapy
- Carcinoma, Renal Cell
- Brain Neoplasms